2-27508073-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001486.4(GCKR):​c.1337T>C​(p.Leu446Pro) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.617 in 1,610,248 control chromosomes in the GnomAD database, including 312,465 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar.

Frequency

Genomes: 𝑓 0.67 ( 35431 hom., cov: 31)
Exomes 𝑓: 0.61 ( 277034 hom. )

Consequence

GCKR
NM_001486.4 missense, splice_region

Scores

1
16
Splicing: ADA: 0.000004368
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: 0.0750

Publications

1182 publications found
Variant links:
Genes affected
GCKR (HGNC:4196): (glucokinase regulator) This gene encodes a protein belonging to the GCKR subfamily of the SIS (Sugar ISomerase) family of proteins. The gene product is a regulatory protein that inhibits glucokinase in liver and pancreatic islet cells by binding non-covalently to form an inactive complex with the enzyme. This gene is considered a susceptibility gene candidate for a form of maturity-onset diabetes of the young (MODY). [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.074255E-6).
BP6
Variant 2-27508073-T-C is Benign according to our data. Variant chr2-27508073-T-C is described in ClinVar as Benign. ClinVar VariationId is 8751.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.851 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GCKRNM_001486.4 linkc.1337T>C p.Leu446Pro missense_variant, splice_region_variant Exon 15 of 19 ENST00000264717.7 NP_001477.2
GCKRXM_017003796.2 linkc.767T>C p.Leu256Pro missense_variant, splice_region_variant Exon 10 of 14 XP_016859285.1
GCKRXM_017003797.2 linkc.767T>C p.Leu256Pro missense_variant, splice_region_variant Exon 9 of 13 XP_016859286.1
GCKRXR_001738699.1 linkn.*5T>C downstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GCKRENST00000264717.7 linkc.1337T>C p.Leu446Pro missense_variant, splice_region_variant Exon 15 of 19 1 NM_001486.4 ENSP00000264717.2
GCKRENST00000411584.1 linkc.437T>C p.Leu146Pro missense_variant, splice_region_variant Exon 5 of 7 3 ENSP00000416917.1
GCKRENST00000478147.1 linkn.534T>C splice_region_variant, non_coding_transcript_exon_variant Exon 2 of 3 5

Frequencies

GnomAD3 genomes
AF:
0.670
AC:
101762
AN:
151894
Hom.:
35360
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.858
Gnomad AMI
AF:
0.708
Gnomad AMR
AF:
0.626
Gnomad ASJ
AF:
0.459
Gnomad EAS
AF:
0.501
Gnomad SAS
AF:
0.757
Gnomad FIN
AF:
0.638
Gnomad MID
AF:
0.490
Gnomad NFE
AF:
0.590
Gnomad OTH
AF:
0.611
GnomAD2 exomes
AF:
0.633
AC:
159003
AN:
251160
AF XY:
0.631
show subpopulations
Gnomad AFR exome
AF:
0.868
Gnomad AMR exome
AF:
0.666
Gnomad ASJ exome
AF:
0.467
Gnomad EAS exome
AF:
0.511
Gnomad FIN exome
AF:
0.643
Gnomad NFE exome
AF:
0.590
Gnomad OTH exome
AF:
0.600
GnomAD4 exome
AF:
0.612
AC:
892119
AN:
1458234
Hom.:
277034
Cov.:
34
AF XY:
0.613
AC XY:
445037
AN XY:
725598
show subpopulations
African (AFR)
AF:
0.863
AC:
28862
AN:
33428
American (AMR)
AF:
0.665
AC:
29720
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.467
AC:
12201
AN:
26112
East Asian (EAS)
AF:
0.468
AC:
18556
AN:
39666
South Asian (SAS)
AF:
0.753
AC:
64859
AN:
86174
European-Finnish (FIN)
AF:
0.646
AC:
34519
AN:
53416
Middle Eastern (MID)
AF:
0.502
AC:
2891
AN:
5762
European-Non Finnish (NFE)
AF:
0.599
AC:
663691
AN:
1108704
Other (OTH)
AF:
0.611
AC:
36820
AN:
60264
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
18320
36640
54960
73280
91600
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18250
36500
54750
73000
91250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.670
AC:
101903
AN:
152014
Hom.:
35431
Cov.:
31
AF XY:
0.669
AC XY:
49718
AN XY:
74306
show subpopulations
African (AFR)
AF:
0.859
AC:
35623
AN:
41488
American (AMR)
AF:
0.626
AC:
9556
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.459
AC:
1591
AN:
3470
East Asian (EAS)
AF:
0.501
AC:
2581
AN:
5150
South Asian (SAS)
AF:
0.757
AC:
3651
AN:
4820
European-Finnish (FIN)
AF:
0.638
AC:
6739
AN:
10566
Middle Eastern (MID)
AF:
0.493
AC:
144
AN:
292
European-Non Finnish (NFE)
AF:
0.590
AC:
40075
AN:
67950
Other (OTH)
AF:
0.615
AC:
1297
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1578
3155
4733
6310
7888
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
800
1600
2400
3200
4000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.604
Hom.:
101372
Bravo
AF:
0.674
TwinsUK
AF:
0.600
AC:
2226
ALSPAC
AF:
0.594
AC:
2290
ESP6500AA
AF:
0.857
AC:
3776
ESP6500EA
AF:
0.583
AC:
5015
ExAC
AF:
0.642
AC:
77990
Asia WGS
AF:
0.695
AC:
2412
AN:
3478
EpiCase
AF:
0.552
EpiControl
AF:
0.553

ClinVar

Significance: Benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Oct 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 33588820, 28082259, 24918535, 22001757, 31118516, 30297969, 30315176, 30420299, 29632382, 29083407, 27516387, 27798624, 23586973, 28385800, 27346689, 26174136, 26043229, 26551672, 27398621, 28008009, 18556336, 23383164, 23894584, 21674002, 21423719, 22182842, 21525158, 19526250, 19643913, 24879641, 22038520, 18678614, 22958899) -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 5 Other:1
Feb 01, 2010
OMIM
Significance:association
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.035
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
11
DANN
Benign
0.040
DEOGEN2
Benign
0.19
T
Eigen
Uncertain
0.29
Eigen_PC
Benign
0.031
FATHMM_MKL
Benign
0.018
N
LIST_S2
Benign
0.24
T
MetaRNN
Benign
0.0000011
T
MetaSVM
Benign
-1.0
T
PhyloP100
0.075
PrimateAI
Benign
0.48
T
PROVEAN
Benign
2.4
N
REVEL
Benign
0.080
Sift
Benign
1.0
T
Sift4G
Benign
0.75
T
Vest4
0.034
MPC
0.087
ClinPred
0.0021
T
GERP RS
3.0
gMVP
0.37
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0000044
dbscSNV1_RF
Benign
0.0040
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1260326; hg19: chr2-27730940; COSMIC: COSV53108202; COSMIC: COSV53108202; API